QCM
CELG

Quest Capital Management’s Celgene Corp CELG Stock Holding History

Quest Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,695
Closed -$249K – 233
2019
Q2 		$249K Buy
+2,695
New +$256K 0.06% 176

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quest Capital Management's CELG Position: Q3 2019 in Review

Quest Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 2,695 shares — an estimated $249K sold.

Quest Capital Management first reported a position in CELG in Q2 2019 and held it in 1 quarter. The position peaked at $249K in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Quest Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Quest Capital Management sold 2,695 Celgene Corp shares in Q3 2019, an estimated $249K.
  • Quest Capital Management first reported a position in Celgene Corp in Q2 2019 and held it in 1 quarter.
  • Quest Capital Management's Celgene Corp position peaked at $249K in Q2 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Quest Capital Management's 13F filing for Q3 2019, filed 29 Oct 2019.